These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

679 related articles for article (PubMed ID: 17942819)

  • 1. Intranasal insulin improves cognition and modulates beta-amyloid in early AD.
    Reger MA; Watson GS; Green PS; Wilkinson CW; Baker LD; Cholerton B; Fishel MA; Plymate SR; Breitner JC; DeGroodt W; Mehta P; Craft S
    Neurology; 2008 Feb; 70(6):440-8. PubMed ID: 17942819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Phase II study targeting amyloid-beta with 3APS in mild-to-moderate Alzheimer disease.
    Aisen PS; Saumier D; Briand R; Laurin J; Gervais F; Tremblay P; Garceau D
    Neurology; 2006 Nov; 67(10):1757-63. PubMed ID: 17082468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Caffeine protects Alzheimer's mice against cognitive impairment and reduces brain beta-amyloid production.
    Arendash GW; Schleif W; Rezai-Zadeh K; Jackson EK; Zacharia LC; Cracchiolo JR; Shippy D; Tan J
    Neuroscience; 2006 Nov; 142(4):941-52. PubMed ID: 16938404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Omega-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD study: a randomized double-blind trial.
    Freund-Levi Y; Eriksdotter-Jönhagen M; Cederholm T; Basun H; Faxén-Irving G; Garlind A; Vedin I; Vessby B; Wahlund LO; Palmblad J
    Arch Neurol; 2006 Oct; 63(10):1402-8. PubMed ID: 17030655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma beta-amyloid and white matter lesions in AD, MCI, and cerebral amyloid angiopathy.
    Gurol ME; Irizarry MC; Smith EE; Raju S; Diaz-Arrastia R; Bottiglieri T; Rosand J; Growdon JH; Greenberg SM
    Neurology; 2006 Jan; 66(1):23-9. PubMed ID: 16401840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of low plasma Abeta42/Abeta40 ratios with increased imminent risk for mild cognitive impairment and Alzheimer disease.
    Graff-Radford NR; Crook JE; Lucas J; Boeve BF; Knopman DS; Ivnik RJ; Smith GE; Younkin LH; Petersen RC; Younkin SG
    Arch Neurol; 2007 Mar; 64(3):354-62. PubMed ID: 17353377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Testosterone improves spatial memory in men with Alzheimer disease and mild cognitive impairment.
    Cherrier MM; Matsumoto AM; Amory JK; Asthana S; Bremner W; Peskind ER; Raskind MA; Craft S
    Neurology; 2005 Jun; 64(12):2063-8. PubMed ID: 15985573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intranasal insulin improves cognition and modulates beta-amyloid in early AD.
    Djupesland PG
    Neurology; 2008 Sep; 71(11):864; author reply 864. PubMed ID: 18779519
    [No Abstract]   [Full Text] [Related]  

  • 9. Association of homocysteine with plasma amyloid beta protein in aging and neurodegenerative disease.
    Irizarry MC; Gurol ME; Raju S; Diaz-Arrastia R; Locascio JJ; Tennis M; Hyman BT; Growdon JH; Greenberg SM; Bottiglieri T
    Neurology; 2005 Nov; 65(9):1402-8. PubMed ID: 16275827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Donepezil treatment of patients with MCI: a 48-week randomized, placebo-controlled trial.
    Doody RS; Ferris SH; Salloway S; Sun Y; Goldman R; Watkins WE; Xu Y; Murthy AK
    Neurology; 2009 May; 72(18):1555-61. PubMed ID: 19176895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of intranasal insulin on cognition in memory-impaired older adults: modulation by APOE genotype.
    Reger MA; Watson GS; Frey WH; Baker LD; Cholerton B; Keeling ML; Belongia DA; Fishel MA; Plymate SR; Schellenberg GD; Cherrier MM; Craft S
    Neurobiol Aging; 2006 Mar; 27(3):451-8. PubMed ID: 15964100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential modulation of plasma beta-amyloid by insulin in patients with Alzheimer disease.
    Kulstad JJ; Green PS; Cook DG; Watson GS; Reger MA; Baker LD; Plymate SR; Asthana S; Rhoads K; Mehta PD; Craft S
    Neurology; 2006 May; 66(10):1506-10. PubMed ID: 16717209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. White matter lesion severity is associated with reduced cognitive performances in patients with normal CSF Abeta42 levels.
    Stenset V; Hofoss D; Johnsen L; Skinningsrud A; Berstad AE; Negaard A; Reinvang I; Gjerstad L; Fladby T
    Acta Neurol Scand; 2008 Dec; 118(6):373-8. PubMed ID: 18510598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progression of mild cognitive impairment to Alzheimer's disease: improved diagnostic value of the combined use of N200 latency and beta-amyloid(1-42) levels.
    Papaliagkas VT; Anogianakis G; Tsolaki MN; Koliakos G; Kimiskidis VK
    Dement Geriatr Cogn Disord; 2009; 28(1):30-5. PubMed ID: 19628938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AMPA potentiator treatment of cognitive deficits in Alzheimer disease.
    Chappell AS; Gonzales C; Williams J; Witte MM; Mohs RC; Sperling R
    Neurology; 2007 Mar; 68(13):1008-12. PubMed ID: 17389305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intranasal insulin improves cognition and modulates beta-amyloid in early AD.
    Dhamoon MS; Noble JM; Craft S
    Neurology; 2009 Jan; 72(3):292-3; author reply 293-4. PubMed ID: 19153380
    [No Abstract]   [Full Text] [Related]  

  • 17. Peripheral insulin and brain structure in early Alzheimer disease.
    Burns JM; Donnelly JE; Anderson HS; Mayo MS; Spencer-Gardner L; Thomas G; Cronk BB; Haddad Z; Klima D; Hansen D; Brooks WM
    Neurology; 2007 Sep; 69(11):1094-104. PubMed ID: 17846409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of beta-hydroxybutyrate on cognition in memory-impaired adults.
    Reger MA; Henderson ST; Hale C; Cholerton B; Baker LD; Watson GS; Hyde K; Chapman D; Craft S
    Neurobiol Aging; 2004 Mar; 25(3):311-4. PubMed ID: 15123336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum amyloid p component as a biomarker in mild cognitive impairment and Alzheimer's disease.
    Verwey NA; Schuitemaker A; van der Flier WM; Mulder SD; Mulder C; Hack CE; Scheltens P; Blankenstein MA; Veerhuis R
    Dement Geriatr Cogn Disord; 2008; 26(6):522-7. PubMed ID: 19052452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma levels of beta-amyloid (1-42) in Alzheimer's disease and mild cognitive impairment.
    Pesaresi M; Lovati C; Bertora P; Mailland E; Galimberti D; Scarpini E; Quadri P; Forloni G; Mariani C
    Neurobiol Aging; 2006 Jun; 27(6):904-5. PubMed ID: 16638622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.